Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock
Investor's Business DailyCrispr won its second gene-editing approval on Tuesday — two months ahead of time. But CRSP stock slipped, and VRTX stock rose minimally.
The post Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock appeared first on Investor&…